Hong Kong-listed biopharmaceutical stocks opened higher, with WuXi AppTec (02359.HK) surging over 10%, followed by gains in other stocks such as WuXi Biologics (02268.HK), Junshi Biosciences (01877.HK), Rongchang Biotech (09995.HK), and Tigermed (03347.HK).